Jacobson Pharma Corporation Limited (HKG:2633)
Hong Kong · Delayed Price · Currency is HKD 1.070
0.00 (0.00%)
Jul 31, 2026, 3:57 PM HKT
HKG:2633 Financials Overview
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 1,569 | 1,569 | 1,577 | 1,468 | 1,268 | 1,596 |
Revenue Growth | 2.35% | -0.47% | 7.43% | 15.79% | -20.55% | 10.35% |
Gross Profit Gross Profit Growth | 677.9 | 677.9 | 692.94 | 620.48 | 538.92 | 620.52 |
Operating Income Operating Income Growth | 387.75 | 387.75 | 432.87 | 311.4 | 269.27 | 248.47 |
Net Income Net Income Growth | 301.62 | 301.62 | 300.83 | 266.97 | 251.04 | 177.67 |
Earnings Per Share EPS Growth | 0.15 | 0.15 | 0.15 | 0.14 | 0.13 | 0.09 |
EPS Growth | -0.60% | -0.33% | 8.96% | 5.89% | 41.57% | 2.30% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Hong Kong Hong Kong Growth | 1,514 | 1,514 | 1,515 | 1,421 | 1,223 | 1,428 |
Macau Macau Growth | 31.59 | 31.59 | 27.63 | 12.9 | 21.65 | 59.62 |
Mainland China Mainland China Growth | 23.34 | 23.34 | 34.58 | 33.39 | 21.05 | 79.97 |
Others Others Growth | 0.2 | 0.2 | 0.1 | - | 1.95 | 14.96 |
Total Total Growth | 1,569 | 1,569 | 1,577 | 1,468 | 1,268 | 1,596 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 419.01 | 419.01 | 548.49 | 458.17 | 1,089 | 530.08 |
Total Debt Total Debt Growth | 910.9 | 910.9 | 773.21 | 749.38 | 1,599 | 1,410 |
Net Cash (Debt) Net Cash Growth | -491.89 | -491.89 | -224.72 | -291.21 | -510.54 | -879.86 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.25 | -0.25 | -0.11 | -0.15 | -0.27 | -0.46 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 328.39 | 328.39 | 526.78 | 484.36 | 630.09 | 406.94 |
Capital Expenditures CapEx Growth | -136.19 | -136.19 | -248.38 | -129.51 | -63 | -63.86 |
Free Cash Flow Free Cash Flow Growth | 192.2 | 192.2 | 278.39 | 354.85 | 567.09 | 343.08 |
Free Cash Flow Growth | -18.28% | -30.96% | -21.55% | -37.43% | 65.29% | -0.82% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 43.19% | 43.19% | 43.94% | 42.27% | 42.52% | 38.89% |
Operating Margin | 24.71% | 24.71% | 27.45% | 21.22% | 21.24% | 15.57% |
Pretax Margin | 23.11% | 23.11% | 23.69% | 17.34% | 19.75% | 14.50% |
Profit Margin | 19.22% | 19.22% | 19.08% | 18.19% | 19.80% | 11.13% |
FCF Margin | 12.25% | 12.25% | 17.66% | 24.18% | 44.74% | 21.50% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.090 | 0.090 | 0.090 | 0.055 | 0.052 | 0.039 |
Dividend Per Share Growth | -69.84% | 0% | 63.64% | 6.18% | 33.51% | 68.70% |
Dividend Yield | 8.41% | 7.32% | 8.46% | 11.19% | 9.68% | 11.54% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 7.09 | 8.16 | 7.79 | 4.42 | 7.35 | 7.01 |
Forward PE | 6.77 | 7.80 | 7.37 | 7.37 | 7.37 | 7.37 |
P/FCF Ratio | 11.14 | 12.80 | 8.42 | 3.33 | 3.26 | 3.63 |
PS Ratio | 1.36 | 1.57 | 1.49 | 0.80 | 1.46 | 0.78 |